Finland· FI-REL-REL48646
Tivicay
A dolutegravir product containing dolutegravir sodium, registered in Finland by ViiV Healthcare BV. The same ATC class is registered in 13 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Dolutegravir is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AJ03 (dolutegravir), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 8 of them publish a price we can compare per daily dose
Dolutegravir · ATC J05AJ03
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dolutegravir costs, country by country.
Normalised to the WHO defined daily dose (50 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Dolutegravir · price per daily dose (50 mg)
USD · FX 28 Sept 2026
- CH Switzerland$25.85
The record
At a glance
Fimea (Finland)- Active substance
- Dolutegravir sodium
- Manufacturer
- ViiV Healthcare BV
- Country
- Finland (FI)
- ATC code
- J05AJ03
- ATC class
- Dolutegravir
- Defined daily dose
- 50 mg, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
94 interactions on record for dolutegravir.
Graded by severity as the source publishes them — 42 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dolutegravir · interactions on record
94 records
- 42 severe
- 3 moderate
- 49 minor
Most severe, free to view
- Magnesium carbonateA02AA01severe
- Magnesium oxideA02AA02severe
- Magnesium hydroxideA02AA04severe
- Kombinationen von AluminiumsalzenA02AB10severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dolutegravir in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesTivicayViiV Healthcare Company
- CzechiaTIVICAYViiV Healthcare BV, Amersfoort
- FranceTIVICAY 10 mg, comprimé pelliculéVIIV HEALTHCARE (PAYS-BAS)
- IrelandTivicay 10 mg film-coated tabletsViiV Healthcare BV
- BelgiumTivicay 10 mgViiV Healthcare
- NetherlandsTivicay 10 mg, filmomhulde tabletViiV healthcare B.V.
- PolandTivicayViiV Healthcare BV
- SwedenTivicay 10 mg Filmdragerad tablettViiV Healthcare BV
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Cyprus · Dogrivio
- Iceland · Tivicay
- Liechtenstein · Tivicay
- Norway · Dolutegravir Teva, Tivicay
- Sweden · Dogrivio, Dolutegravir Elpen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8c48cdad-3a32-4f1b-b65d-a171a21c569f GET /v1/drugs/8c48cdad-3a32-4f1b-b65d-a171a21c569f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "50",
"form": "tabletti, kalvopäällysteinen",
"route": "Suun kautta",
"ddd_unit": "mg",
"strength": "10 mg",
"atc_label": "dolutegraviiri",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/13/892/003-004",
"fimea_rel_id": "REL48646",
"authorised_at": "2017-02-23"
}See everything about dolutegravir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.